Collaborations to Enhance Drug Development and Regulatory Science

Summary

This is a forecasted federal grant opportunity issued by the Food and Drug Administration (FDA) under the Department of Health and Human Services (HHS). It focuses on collaborations to enhance drug development and regulatory science. The opportunity was forecasted as of November 30, 2023, but full solicitation details, scope, and requirements had not yet been published at the time of this notice.

Risks & flags

• Opportunity is only a forecast — no full solicitation text, scope, budget, or requirements are available; all extracted fields are minimal and should be treated as preliminary
• No response deadline published — bidders cannot confirm eligibility or begin proposal development with confidence